Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors
about
Viral quasispecies evolutionCopy number variation of genes involved in the hepatitis C virus-human interactomePredicting the outcomes of combination therapy in patients with chronic hepatitis C using artificial neural network.Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcomeAnalysis of HCV quasispecies dynamic under selective pressure of combined therapy.Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patientsInterleukin-28B genotyping by melt-mismatch amplification mutation assay PCR analysis using single nucleotide polymorphisms rs12979860 and rs8099917, a useful tool for prediction of therapy response in hepatitis C patients.Amino Acid Polymorphisms Within the Entire HCV NS5A Region in Estonian Chronic HCV 1b Patients With Different Treatment Response.Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patient.The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia.Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy.Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms.Osteopontin as a marker for response to pegylated interferon Alpha-2b treatment in Chronic HCV Saudi patients.
P2860
Q27013917-A0F0EC23-91BB-443B-B42C-789A20C76F18Q27468888-ABD32861-67B6-4DC7-8F1A-47806E014026Q33808119-40F32E91-C4D4-4E14-9918-7920E351305CQ34485144-DDDABAD7-6740-4A19-8087-5F78779B3C46Q34572396-57AB8F51-14AF-4D5E-A932-09FCEAC44AD8Q34981566-2C7D6057-DCAE-4833-9641-4ACEF1FC1DA8Q35140158-252EC5E5-3C31-4D07-AFF2-C0F053E58685Q37401160-04D30D65-782F-4467-A8EC-C904B45DBAC2Q37701225-D4F3A993-CAAA-439E-A80D-A4995A254900Q39112435-8AF75398-9F4C-4786-9D6E-0D550C1C65C6Q39204755-726486D9-B1B1-4D1E-9530-D2EAE17DB3A4Q39450473-F7E962AB-5394-4C0D-98B2-9C2736B5C9ADQ41480323-AF86BA35-B113-4394-8E64-2891CBAEB3F8Q46606704-CD96F057-CBCD-41F5-8FEB-B0B2DBBB5061
P2860
Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Baseline prediction of combina ...... s using viral and host factors
@ast
Baseline prediction of combina ...... s using viral and host factors
@en
type
label
Baseline prediction of combina ...... s using viral and host factors
@ast
Baseline prediction of combina ...... s using viral and host factors
@en
prefLabel
Baseline prediction of combina ...... s using viral and host factors
@ast
Baseline prediction of combina ...... s using viral and host factors
@en
P2860
P50
P1433
P1476
Baseline prediction of combina ...... s using viral and host factors
@en
P2093
Mercè Ardèvol
Ramón Planas
P2860
P304
P356
10.1371/JOURNAL.PONE.0014132
P407
P50
P577
2010-11-30T00:00:00Z